Cite
Chou WC, Lai CC, Hung CY, et al. Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy. Cancer Control. 2022;29:10732748211045276doi: 10.1177/10732748211045276.
Chou, W. C., Lai, C. C., Hung, C. Y., Hsueh, S. W., Yeh, K. Y., Lu, C. H., Tsang, N. M., Chang, P. H., Ho, Y. W., Chen, S. Y., Lin, Y. C., & Hung, Y. S. (2022). Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy. Cancer control : journal of the Moffitt Cancer Center, 2910732748211045276. https://doi.org/10.1177/10732748211045276
Chou, Wen-Chi, et al. "Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy." Cancer control : journal of the Moffitt Cancer Center vol. 29 (2022): 10732748211045276. doi: https://doi.org/10.1177/10732748211045276
Chou WC, Lai CC, Hung CY, Hsueh SW, Yeh KY, Lu CH, Tsang NM, Chang PH, Ho YW, Chen SY, Lin YC, Hung YS. Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy. Cancer Control. 2022 Jan-Dec;29:10732748211045276. doi: 10.1177/10732748211045276. PMID: 34994207; PMCID: PMC8744172.
Copy
Download .nbib